IRS-1 gene polymorphism and DNA damage in pregnant women with diabetes or mild gestational hyperglycemia

Diabetology and Metabolic Syndrome

Volumn 7, Issue 1, 2015, Pages

  Gelaleti, Rafael B ^a   Damasceno, Débora C ^a   Salvadori, Daisy M F ^a   Marcondes, João Paulo C ^a   Lima, Paula H O ^a   Morceli, Glilciane ^a   Calderon, Iracema M P ^a   Rudge, Marilza V C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Diabetes; DNA damage; Mild gestational hyperglycemia; Newborn; Polymorphism; Pregnancy

Indexed keywords

ARGININE; INSULIN RECEPTOR SUBSTRATE 1;

ADULT; ARTICLE; BRAZILIAN; COMET ASSAY; CONTROLLED STUDY; DIET THERAPY; DNA DAMAGE; EXERCISE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; LYMPHOCYTE; MAJOR CLINICAL STUDY; MILD GESTATIONAL HYPERGLYCEMIA; NEWBORN; ORAL GLUCOSE TOLERANCE TEST; POLYMERASE CHAIN REACTION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UMBILICAL CORD BLOOD; YOUNG ADULT;

EID: 84926687705     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/s13098-015-0026-3     Document Type: Article

References (47)

1. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453-9.
2. Rudge MVC, Calderon IMP, Ramos MD, Abbade JF, Rugolo LMSS. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10 year analysis. Gynecol Obst Invest. 2000;50:108-12.
3. Negrato CA, Jovanovic L, Tambascia MA, Calderon IMP, Geloneze B, Dias A, et al. Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008;24(4):324-30.
4. Silva MRG, Calderon IMP, Gonçalves LC, Aragon FF, Padovani CR, Pimenta WP. Ocorrência de diabetes melito em mulheres com hiperglicemia em gestação prévia. Rev Saude Publica. 2003;37:345-50.
5. Watanabe RM, Valle T, Hauser ER, Ghosh S, Eriksson J, Kohtamäki K, et al. The Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Hum Hered. 1999;49:159-68.
6. Carvalheira JBC, Zecchin HG, Saad MJ. Vias de Sinalização da Insulina. Arq Bras Endocrinol Metab. 2002;vol46 n4.
7. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105-16.
8. Saxena R, Hivert M, Langenberg C, Tanaka T, Pankow J, Lyssenko V, et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010;42(2):142-8.
9. Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proença C, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009;41:1110-5.
10. Porzio O, Federici M, Hribal M. The Arg972 amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic ß cells. J Clin Invest. 1999;104:357-64.
11. Tok EC, Ertunc D, Bilgin O, Erdal EM, Kaplanoglu M, Dilek S. Association of insulin receptor substrate-1 G972R variant with baseline characteristics of the patients with gestational diabetes mellitus. Am J Obstet Gynecol. 2006;194(3):868-72.
12. Gelaleti RB, Lima PHO, Damasceno DC, Calderon IMP, Rudge MVC. Diabetes e o Polimorfismo Gly972Arg - Atualização Bibliográfica. Diabetes Clínica. 2011. v04p204/04-209.
13. Vergotine Z, Kengne AP, Erasmus RT, Matsha TE. No evidence for association of insulin receptor substrate-1 Gly972Arg variant with type 2 diabetes mellitus in a mixed-ancestry population of South Africa. S Afr Med J. 2014;104(6):420-3.
14. Wright Jr E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract. 2006;60(3):308-14.
15. Dinçer Y, Akçay T, Ilkova H, Alademir Z, Ozbay G. DNA damage and antioxidant defense in peripheral leukocytes of patients with type 1 diabetes mellitus. Mutat Res. 2003;527:49-55.
16. Pitozzi V, Giovannelli L, Bardini G, Rotella CM, Dolara P. Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. Mutat Res. 2003;28:129-33.
17. Zengi A, Ercan G, Caglayan O, Tamsel S, Karadeniz M, Simsir I, et al. Increased oxidative DNA damage in lean normoglycemic offspring of type 2 diabetic patients. Exp Clin Endocrinol Diabetes. 2011;119:467-71.
18. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768-73.
19. Gilmer MDG, Beard RW, Brooke FM, Oakley NW. Carbohydrate metabolism in pregnancy. Part I. Diurnal plasma glucose profi le in normal and diabetic women. Br Med J. 1975;3(5980):399-402.
20. Rudge MVC, Calderon IMP, Ramos MD, Maestá I, Souza LMS, Peraçoli JC. Perspectiva perinatal decorrente do rígido controle pré-natal em gestações complicadas pelo diabete. RBGO. 1995;17:26-32.
21. American Diabetes Association (ADA). Diagnosis and classification of diabete mellitus. Diabetes Care. 2010;33 Suppl 1:S62-9.
22. Salazar LA, Hirata MH, Cavalli SS, Machado MO, Hirata RD. Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem. 1998;44:1748-50.
23. Almind K, Bjørbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 1993;342(8875):828-32.
24. Collins AR, Raslová K, Smorovská MP, Petrovská H, Ondrusová A, Vohnout B, et al. DNA damage in diabetes: correlation with a clinical marker. Free Rad Biol Med. 1998;25:373-7.
25. Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Zurawska M, et al. DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 2004;554:297-304.
26. Orkunoglu SFE, Mergen H, Bolu E, Ozata M. Molecular scanning for mutations in the insulin receptor substrate (Irs-1) gene in Turkish with type 2 diabetes mellitus. Endocr J. 2005;52(5):593-8.
27. Jellema A, Mensink RP, Kromhout D, Saris WH, Feskens EJ. Metabolic risk markers in an overweight and normal weight population with oversampling of carriers of the IRS-1 972Arg-variant. Atherosclerosis. 2003;171(1):75-81.
28. Fallucca F, Dalfrà MG, Sciullo E, Masin M, Buongiorno AM, Napoli A, et al. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy. Metabolism. 2006;55(11):1451-6.
29. Negrato CA, Jovanovic L, Rafacho A, Tambascia MA, Geloneze B, Dias A, et al. Association between different levels of dysglycemia and metabolic syndrome in pregnancy. Diabetol Metab Syndr. 2009;1(1):3.
30. Rett K, Koch M, Volk A, Maerker E, Jacob S, Haering HU, et al. Codon 972 polymorphism of the IRS-1 gene is prevalent in offspring of subjects with type 2 diabetes without determining clamp-derived insulin action. Diabetes. 1998;47 Suppl 1:393a. Abstr.
31. Zhang Y, Wat N, Stratton IM, Warren-Perry MG, Orho M, Groop L, et al. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. Diabetologia. 1996;39:1505-11.
32. Shirakami A, Toyonaga T, Tsuruzoe K, Shirotani T, Matsumoto K, Yoshizato K, et al. Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes. J Endocrinol. 2002;174(2):309-19.
33. Mattar R, Torloni MR, Betrán AP, Merialdi M. Obesity and pregnancy. Rev Bras Ginecol Obstet. 2009;31:107-10.
34. Karbownik-Lewinska M, Szosland J, Kokoszko-Bilska A, Stępniak J, Zasada K, Gesing A, et al. Direct contribution of obesity to oxidative damage to macromolecules. Neuro Endocrinol Lett. 2012;33(4):453-61.
35. Wayhs CA, Manfredini V, Sitta A, Deon M, Ribas GS, Vanzin CS, et al. Effects of insulin and clonazepam on DNA damage in diabetic rats submitted to the forced swimming test. Mutat Res. 2010;703(2):187-90.
36. Wang JS, Huang YH. Effects of exercise intensity on lymphocyte apoptosis induced by oxidative stress in men. Eur J Appl Physiol. 2005;95(4):290-7.
37. Kim KS, Paik IY, Woo JH, Kang BY. The effect of training type on oxidative DNA damage and antioxidant capacity during three-dimensional space exercise. Med Princ Pract. 2010;19(2):133-41.
38. Siu PM, Pei XM, Teng BT, Benzie IF, Ying M, Wong SH. Habitual exercise increases resistance of lymphocytes to oxidant-induced DNA damage by upregulating expression of antioxidant and DNA repairing enzymes. Exp Physiol. 2011;96(9):889-906.
39. Staruchová M, Volková K, Lajdová A, Misl'anová C, Collins A, Wsólová L, et al. Importance of diet in protection against oxidative damage. Neuro Endocrinol Lett. 2006;27 Suppl 2:112-5.
40. Ochi H, Sakai K. Oxidative stress profile: OSP. Rinsho Byori. 2003;51(2):115-25.
41. Simońska-Cichocka E, Gumprecht J, Zychma M, Witkowska A, Misiołek H, Slawska H, et al. The polymorphism in insulin receptor substrate-1 gene and birth weight in neonates at term. Endokrynol Pol. 2008;59(3):212-6.
42. Bezerra RMN, Castro V, Sales T, PassiniJr R, Marba STM, Saad ST, et al. The Gly972Arg polymorphism in Insulin receptor substrate-1 is associated with decreased birth weight in a population-based sample of Brazilian newborns. Diabetes Care. 2002;25(3):550-3.
43. Clausen JO, Hansen T, Bjørbaek C, Echwald SM, Urhammer SA, Rasmussen S, et al. Insulin resistance: interaction between obesity and a common variant of insulin receptor substrate-1. Lancet. 1995;346:397-402.
44. Imai Y, Fusco A, Suzuki Y, Lesniak MA, D'Alfonso R, Sesti G, et al. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1994;79:1655-8.
45. Le Fur S, Le Stunff C, Bougnères P. Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphisms. Diabetes. 2002;51(l3):304-7.
46. Rudge MVC. Perfil glicêmico e teste de tolerância oral à glicose no diagnóstico do diabete na gravidez. (Livre-Docência). Botucatu: Faculdade de Medicina, Universidade Estadual Paulista; 1983.
47. Rudge MVC, Calderon IMP, Ramos MD, Brasil MAM, Rugolo LMSS, Bossolan G, et al. Hiperglicemia materna diária diagnosticada pelo perfil glicêmico: um problema de saúde pública materno e perinatal. Rev Bras Ginecol Obstet. 2005;27:691-7.